학술논문
1077 A PHASE 2, OPEN-LABEL, MULTICENTER, 2X2 CROSSOVER TRIAL TO ASSESS THE SAFETY AND EFFICACY OF MS1819-SD IN PATIENTS WITH EXOCRINE PANCREATIC INSUFFICIENCY DUE TO CYSTIC FIBROSIS
Document Type
Abstract
Author
Source
In Gastroenterology May 2020 158(6) Supplement 1:S
Subject
Language
ISSN
0016-5085